MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: US Venture
OncoMed Pharmaceuticals (NASDAQ:OMED)
Organization & Developments: OncoMed
Parents
2013: The $100M Club: Where the Major League Life Sciences Companies Are (2013)
OncoMed Pharmaceuticals (NASDAQ:OMED)
Children
2016: Biotech Forum Daily Digest: Biotech Ready To Bounce Back On Brexit Polls. FDA's Advice For Major Oncology Concerns. Spotlight On OncoMed Pharmaceuticals.
2016: It has over a half dozen candidates in the pipeline
Biological therapeutics targeting cancer stem cells
OncoMed has shown an ability to attack cancer stem cells, which resist traditional chemotherapy.
Therapies that target tumor-causing cancer stem cells.
Jumps
*Key People: OncoMed
Finance & Acquisition: OncoMed